COVID-19 pandemic: The value of antibody testing for imaging facilities

CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2020; 30(03): 251-252
DOI: 10.4103/ijri.IJRI_819_20

Editorial

Anirudh Kohli

Breach Candy Hospital and Research Centre, 60 Bhulabhai Desai Road, Mumbai, Maharashtra, India

References
1 Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv 2020; published online April 20. doi: 10.1101/2020.03.30.20047365 (preprint)
2 Liu W, Liu L, Kou G, Zheng Y, Ding Y, Ni W. et al. Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2. J Clin Microbiol 2020; 58
3 Siddiqui A, Naushin S, Pradhan S, Misra A, Tyagi A, Loomba M. et al. SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting. medRxiv
4 Naidich JJ, Boltyenkov A, Wang JJ, Chusid J, Hughes D, Sanelli PC. Impact of the Coronavirus disease 2019 (COVID-19) pandemic on imaging case volumes. J Am Coll Radiol 2020; 17: 865-72